Cidara Therapeutics' Series A Round

Cidara Therapeutics raised a round of funding on June 30, 2014.

Cidara, Therapeutics, formerly K2 Therapeutics, is a privately held biotechnology company focused on the discovery, development and commercialization of anti-infectives for the treatment of disease. C…

Articles about Cidara Therapeutics' Series A Round: